quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:25:33·25d
ANALYSTRating
Nuvalent Inc. logo

Wells Fargo initiated coverage on Nuvalent with a new price target

NUVL· Nuvalent Inc.
Health Care
Original source

Companies

  • NUVL
    Nuvalent Inc.
    Health Care

Recent analyst ratings

  • Mar 30UpdateWells Fargo$116.00
  • Nov 24UpdateTruist-
  • Nov 12UpdateCanaccord Genuity$126.00
  • Oct 16UpdateStifel$115.00
  • Oct 15UpdateCantor Fitzgerald$135.00
  • Sep 4UpdateGuggenheim$122.00

Related

  • PR2d
    Nuvalent to Present Pivotal Data from ALKOVE-1 Trial of Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC at the 2026 American Society of Clinical Oncology Annual Meeting
  • PR6d
    New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
  • INSIDER10d
    SEC Form 4 filed by Pelish Henry E.
  • INSIDER15d
    SEC Form 4 filed by Porter James Richard
  • SEC17d
    Nuvalent Inc. filed SEC Form 8-K: Other Events
  • PR17d
    Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC
  • INSIDER20d
    SEC Form 4 filed by Balcom Alexandra
  • INSIDER21d
    SEC Form 4 filed by Lane Benjamin
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022